Dr. Omid Farokhzad

Dr. Omid Farokhzad |Clyto Access

Associate Professor, Harvard Medical School, USA

Organizing Committee Member

Expertise:

Biography: Omid Farokhzad is an Associate Professor at Harvard Medical School (HMS) and a physician-scientist in the Department of Anesthesiology at Brigham and Women’s Hospital (BWH). Dr. Farokhzad directs the Laboratory of Nanomedicine and Biomaterials at BWH. He is a Distinguished Adjunct Professor at the King Abdulaziz University in Jeddah, Saudi Arabia. He is a faculty member of the Brigham Research Institute Cancer Research Center. He is additionally a member of the Dana Farber/Harvard Cancer Center Programs in Prostate Cancer and Cancer Cell Biology. Dr. Farokhzad’s research is focused on the development of therapeutic nanoparticle technologies; most notably, he pioneered the high throughput combinatorial development and screening of multifunctional nanoparticles for medical applications. Dr. Farokhzad has authored approximately 120 papers and holds more than 140 issued/pending US and International patents. The technologies that Dr. Farokhzad has developed with collaborators at HMS and MIT formed the basis for the launch of three biotechnology companies: BIND Therapeutics (NASDAQ: BIND), Selecta Biosciences, Blend Therapeutics, which are translating the aforementioned academic innovations toward commercialization and societal impact. Dr. Farokhzad has served in various capacities on the Board of Directors and the Scientific Advisory Board of these companies. Dr. Farokhzad was elected to the College of the Fellows of the American Institute of Medical and biological Engineering. He was a recipient of the 2013 RUSNANOPRIZE, one of the largest international nanotechnology prizes, for the development and industrialization of nanoparticle technologies for medical applications. In 2014, he received the Golden Door Award from the International Institute of New England for his societal and economic impact as a naturalized USA citizen, and in the same year he was also selected by Thomson Reuters as one of the World’s Most Influential Scientific Minds, which recognizes the most highly cited scientists across numerous disciplines such as biology, chemistry, physics, immunology, economics and engineering. In 2013, the Boston Globe selected him among the top innovators in Massachusetts and the Boston Business Journal selected him among the Health Care Champions for his innovations. In 2012, he was among the regional Ernst & Young Entrepreneur of the Year awardees. Dr. Farokhzad completed his post-graduate clinical and post-doctoral research trainings, respectively, at the BWH/HMS and MIT in the laboratory of Institute Professor Robert Langer. He received his M.D. and M.A. from Boston University School of Medicine and his M.B.A. from the Sloan School of Management at MIT.

Related Conferences :

World Summit on Nanotechnology and Nanomedicine Research